NCT01606566 2022-02-18A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.PCI Biotech ASPhase 2 Terminated26 enrolled
NCT01872923 2014-06-16Dose Escalating Study for Amphinex-based PCI of Bleomycin.PCI Biotech ASPhase 1 Completed3 enrolled
NCT00002476 2013-08-02Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck CancerNational Cancer Institute (NCI)Phase 3 Completed